Blood cancer Clinical Trials in Boston, MA

As of September 2026, 139 paid clinical trials are recruiting for Blood cancer in Boston, Massachusetts. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

140 clinical trials for Blood cancer

·Clear filters·

Email me when a new blood cancer trial opens in Boston, MA.

IS-free Treg HaploHCT

for Stem Cell Transplant Complications

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 75

Code: NCT04678401·Phase 1·Recruiting·Listed Dec 2020

Apply to this trial

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

for Bone Marrow Transplant Complications

Sites in Boston +2 more locations

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT06472089·Recruiting·Listed Jun 2024

Apply to this trial

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Boston +2 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT03113643·Phase 1·Recruiting·Listed Apr 2017

Apply to this trial

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

for Myeloproliferative Disorders

3 locations in Boston

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT05842603·Recruiting·Listed May 2023

Apply to this trial

HEME Home Transfusion Program

for Leukemia

2 locations in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT06487247·Recruiting·Listed Jul 2024

Apply to this trial

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

for Lymphoma

Drug: Epcoritamab

Sites in Boston +2 more locations

Sponsor: Beth Israel Deaconess Medical Center

Sex: All·Age: 18+

Code: NCT06510361·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Ziftomenib Maintenance Post Allo-HCT

for Acute Myeloid Leukemia

Sites in Boston +1 more location

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT06440135·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Emapalumab Prevention of CAR-T Cell Associated Toxicities

for Large B-cell Lymphoma

2 locations in Boston

Sponsor: Marcela V. Maus, M.D.,Ph.D.

Sex: All·Age: 18+

Code: NCT06550141·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Acute Myeloid Leukemia

1 location in Boston

Sponsor: Eric Stephen Winer, MD

Sex: All·Age: 18+

Code: NCT05703542·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

Sites in Boston +28 more locations

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

The CARDIOPROTECT Trial

for Diffuse Large B-cell Lymphoma (DLBCL)

1 location in Boston

Sponsor: Beth Israel Deaconess Medical Center

Sex: All·Age: 18+

Code: NCT07654426·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

for Myelofibrosis

Drug: Ruxolitinib

Sites in Boston +29 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07623161·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia

for Leukemia, Myeloid

Drug: Venetoclax

2 locations in Boston

Sponsor: Jacqueline Garcia, MD

Sex: All·Age: 18 - 90

Code: NCT07439211·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

for Multiple Myeloma

1 location in Boston

Sponsor: Andrew Hantel, MD

Sex: All·Age: 18+

Code: NCT07341867·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

ALL Backbone in AYAs

for Acute Lymphoblastic Leukemia

1 location in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 51

Code: NCT07227584·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for Multiple Myeloma

Sites in Boston +10 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05714839·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

for Multiple Myeloma

Sites in Boston +7 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06106945·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for Chronic Lymphocytic Leukaemia

Sites in Boston +11 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06564038·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

for Lymphoma

Sites in Boston +6 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12+

Code: NCT06137144·Phase 1, Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Conditions in Blood cancer (Boston, MA)

Acute myeloid leukemia (AML)· 35 Non-Hodgkin lymphoma· 33 Multiple myeloma· 30 Chronic lymphocytic leukemia (CLL)· 21 Leukemia (other)· 19 Myelodysplastic syndromes (MDS)· 19 Hematologic malignancy· 16 Follicular lymphoma· 11 Small lymphocytic lymphoma· 11 Myelofibrosis· 10 Diffuse large B-cell lymphoma (DLBCL)· 10 Mantle cell lymphoma· 8 Myeloproliferative neoplasm· 7 Acute lymphoblastic leukemia· 6 Hodgkin lymphoma· 6 Marginal zone lymphoma· 5 Chronic myelomonocytic leukemia· 3 Burkitt lymphoma· 2